Management of Mild to Moderate Alzheimer Disease: Defining the Role of Rivastigmine

By Plosker G.L.   Keating G.M.  

Disease Management & Health Outcomes, Vol. 12, Iss. 1, 2004-01 ,pp. : 55-72

Adis International

Access to resources Recommend Favorite

Cost-Effectiveness of the Nicotine Transdermal Patch

By Stapleton J.  

Preventive Medicine, Vol. 27, Iss. 2, 1998-02 ,pp. : 304-304

Academic Press

Access to resources Recommend Favorite

Drug delivery strategies for Alzheimer's disease treatment

By Di Stefano Antonio   Iannitelli Antonio   Laserra Sara   Sozio Piera  

Expert Opinion on Drug Delivery, Vol. 8, Iss. 5, 2011-05 ,pp. : 581-603

Informa Healthcare

Access to resources Recommend Favorite

Diffusion of innovations: treatment of Alzheimer's disease in Germany

By Ruof J.   Mittendorf T.   Pirk O.   Graf von der Schulenburg J.-M.  

Health Policy, Vol. 60, Iss. 1, 2002-04 ,pp. : 59-66

Elsevier

Access to resources Recommend Favorite

Adhesive properties: a critical issue in transdermal patch development

By Cilurzo Francesco   Gennari Chiara G M   Minghetti Paola  

Expert Opinion on Drug Delivery, Vol. 9, Iss. 1, 2012-01 ,pp. : 33-45

Informa Healthcare

Access to resources Recommend Favorite